Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Halperin

Showing results (491-500 of 544) with videos related to

Pageof 55
Sort By:
Plos One|November 10, 2023
Maternal varicella antibodies in children aged less than one year: Assessment of antibody decayShelly Bolotin, Stephanie L Hughes, Rachel D Savage, et al.
Human Vaccines & Immunotherapeutics|June 12, 2019
Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) studyShelly Bolotin, Alberto Severini, Todd Hatchette, et al.
The Pediatric Infectious Disease Journal|February 12, 2009
Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infantsKirsten P Perrett, Matthew D Snape, Karen J Ford, et al.
Vaccine|May 1, 2022
Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) studySelma Osman, Natasha Crowcroft, Elizabeth McLachlan, et al.
JAMA|January 10, 2008
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trialMatthew D Snape, Kirsten P Perrett, Karen J Ford, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4GEvangelos Papadopoulos, Simon Jenni, Eihab Kabha, et al.
Pediatrics|April 20, 2021
Health Outcomes in Young Children Following Pertussis Vaccination During PregnancyMeghan Laverty, Natasha Crowcroft, Shelly Bolotin, et al.
Vaccine|January 7, 2009
Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of ageScott A Halperin, Bruce Tapiero, Francisco Diaz-Mitoma, et al.
Vaccine|September 4, 2023
Factors associated with intention for revaccination among patients with adverse events following immunizationCaroline E Muñoz, Anne Pham-Huy, Jeffrey M Pernica, et al.
Lancet Regional Health. Americas|December 1, 2025
Healthcare costs and resource utilization for acute respiratory syncytial virus pediatric hospitalizations in Canada: a population-based studyNirma Khatri Vadlamudi, Kyle Gomes, Ethan Chow, et al.
Pageof 55

Showing results (491-500 of 544) with videos related to

Sort By:
Pageof 55
Plos One|November 10, 2023
Maternal varicella antibodies in children aged less than one year: Assessment of antibody decayShelly Bolotin, Stephanie L Hughes, Rachel D Savage, et al.
Human Vaccines & Immunotherapeutics|June 12, 2019
Assessment of population immunity to measles in Ontario, Canada: a Canadian Immunization Research Network (CIRN) studyShelly Bolotin, Alberto Severini, Todd Hatchette, et al.
The Pediatric Infectious Disease Journal|February 12, 2009
Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infantsKirsten P Perrett, Matthew D Snape, Karen J Ford, et al.
Vaccine|May 1, 2022
Population immunity to measles in Canada using Canadian Health Measures survey data - A Canadian Immunization Research Network (CIRN) studySelma Osman, Natasha Crowcroft, Elizabeth McLachlan, et al.
JAMA|January 10, 2008
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trialMatthew D Snape, Kirsten P Perrett, Karen J Ford, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Structure of the eukaryotic translation initiation factor eIF4E in complex with 4EGI-1 reveals an allosteric mechanism for dissociating eIF4GEvangelos Papadopoulos, Simon Jenni, Eihab Kabha, et al.
Pediatrics|April 20, 2021
Health Outcomes in Young Children Following Pertussis Vaccination During PregnancyMeghan Laverty, Natasha Crowcroft, Shelly Bolotin, et al.
Vaccine|January 7, 2009
Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of ageScott A Halperin, Bruce Tapiero, Francisco Diaz-Mitoma, et al.
Vaccine|September 4, 2023
Factors associated with intention for revaccination among patients with adverse events following immunizationCaroline E Muñoz, Anne Pham-Huy, Jeffrey M Pernica, et al.
Lancet Regional Health. Americas|December 1, 2025
Healthcare costs and resource utilization for acute respiratory syncytial virus pediatric hospitalizations in Canada: a population-based studyNirma Khatri Vadlamudi, Kyle Gomes, Ethan Chow, et al.
Pageof 55